Amlodipine Besylate

苯磺酸氨氯地平

Report date: 2022/07/19 09:53:01
NME

Base Information

Drug NameAmlodipine Besylate
Drug Alias NameamlodipineamlodipinoamlodipinumAmlodipine BesilateIstin +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsIron Overloadbeta-ThalassemiaThalassemia +[13] 
Global Approved IndicationsHypertensionCoronary Artery DiseaseAngina, Stable +[5] 
Approved Indications in ChinaHypertensionAngina, StableAngina Pectoris, Variant
Original Approved Country/TerritoryUnited Kingdom
Original Approved Date1989/03/01
Country/TerritoryCanadaUnited StatesTaiwan +[9] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncViatris Specialty LLCHui Zhi Pharmaceutical (Dalian) Co Ltd
Inactive CompaniesHanmi Pharmaceutical Co LtdViatrisOverseas Pharmaceuticals Ltd +[12] 
Active IndicationsHypertensionCoronary Artery DiseaseAngina, Stable +[5] 
Inactive IndicationsIron Overloadbeta-ThalassemiaThalassemia +[8] 

Other Information

ATC CodeC08CA01
Related LinksWikipediaDrugBankKEGG